Cargando…
Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small “Non-Natural” Peptides
The addictive nature of nicotine is likely the most significant reason for the continued prevalence of tobacco smoking despite the widespread reports of its negative health effects. Nicotine vaccines are an alternative to the currently available smoking cessation treatments, which have limited effic...
Autores principales: | Le, Hoang-Thanh, Fraleigh, Nya L., Lewicky, Jordan D., Boudreau, Justin, Dolinar, Paul, Bhardwaj, Nitin, Diaz-Mitoma, Francisco, Montaut, Sabine, Fallahi, Sarah, Martel, Alexandrine L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143940/ https://www.ncbi.nlm.nih.gov/pubmed/32178357 http://dx.doi.org/10.3390/molecules25061290 |
Ejemplares similares
-
Assessing Neutralized Nicotine Distribution Using Mice Vaccinated with the Mucosal Conjugate Nicotine Vaccine
por: Fraleigh, Nya L., et al.
Publicado: (2021) -
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
por: Fraleigh, Nya L., et al.
Publicado: (2019) -
Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy
por: Lewicky, Jordan D., et al.
Publicado: (2022) -
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats
por: Oliva, Reynaldo, et al.
Publicado: (2019) -
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
por: Fraleigh, Nya L., et al.
Publicado: (2016)